Curia’s Albuquerque Facility Gets Major Upgrade
Curia, a contract development and manufacturing organisation, is making significant strides in its expansion project in Albuquerque, NM. The project, managed by BE&K Building Group,…
Curia, a contract development and manufacturing organisation, is making significant strides in its expansion project in Albuquerque, NM. The project, managed by BE&K Building Group,…
Delpharm, a Contract Development and Manufacturing Organisation (CDMO), has announced the expansion of its pharmaceutical network with the acquisition of Astellas’ Meppel pharmaceutical manufacturing facility…
In a significant move that signals the ongoing reshaping of the Contract Development and Manufacturing Organisation (CDMO) industry, Recipharm has sold off seven of its manufacturing and…
Bespak contract development and manufacturing organisation (CDMO), has announced the completion of its separation from Recipharm’s former Advanced Delivery Systems Business Unit to form a…
Bora Pharmaceuticals has announced the successful completion of its acquisition of Upsher-Smith Laboratories, LLC a generics manufacturer based in Minnesota, U.S. Through this acquisition, Bora significantly expands…
Lonza has appointed Wolfgang Wienand as Chief Executive Officer, to join the company during the summer of 2024. Wolfgang currently holds the position of CEO…
Kemwell BioPharma, India’s largest biologics contract development and manufacturing organisation (CDMO), has announced the implementation of the Veeva Vault Quality Management System (QMS) across its…
An affiliate of Aterian Investment Partners, a private investment firm, has agreed to recapitalise Contract Pharmaceuticals Limited Canada (CPL), a North American contract development and manufacturing…
Intravacc and Primrose Bio have partnered to enhance the development and supply of conjugate vaccines, leveraging their respective strengths in vaccine development and supply chain…
Aragen, a Contract Research Development and Manufacturing Organisation (CRDMO) specialising in small molecules and biologics, has announced the operationalisation of the first phase of its…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.